NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Pregnancy and COVID-19

Investigational Antivirals for Managing COVID-19

COVID-19 in people with rheumatic diseases: risks, outcomes

Remdesivir in pregnant women with moderate to severe coronavirus

COVID, Free Full-Text

Studies, Emory University

Baricitinib in Combination with Remdesivir Reduces Time to

Management of Patients With COVID-19

New Perspectives on Antimicrobial Agents: Remdesivir Treatment for

Remdesivir Now Approved for COVID Outpatients, Too

Outpatient Treatment Options for Acute COVID-19 ​

Summary of Guidance for Minimizing the Impact of COVID-19 on

Mild or Moderate Covid-19

Diagnosis and management of covid-19 in pregnancy

Management of Patients With COVID-19